<DOC>
	<DOCNO>NCT01952535</DOCNO>
	<brief_summary>The objective study determine safety profile , tolerability , pharmacokinetics pharmacodynamics HMS5552 follow single ascend dos healthy adult subject .</brief_summary>
	<brief_title>A Clinical Study Evaluate Safety , Tolerability Pharmacokinetics Oral HMS5552 Healthy Volunteers</brief_title>
	<detailed_description>This randomize , double-blind placebo-controlled safety study single oral dos HMS5552 give healthy volunteer . The primary objective characterize safety profile HMS5552 follow single ascend dos ( SAD ) healthy adult subject . The secondary objective include : 1 . To assess pharmacokinetic profile HMS5552 single dose 2 . To assess preliminary pharmacodynamic profile HMS5552 Each study subject receive single oral dose HMS5552 . During dose , eight subject allocate receive HMS5552 two subject allocate receive placebo treatment . Several dos HMS5552 test . Dose titration reduction determine cohort base safety pharmacokinetic data obtain low dose cohort .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Female male volunteer , 18 45 year age BMI : 18 24 kg/m2 Fasting plasma glucose : 3.9 6.1 mmol/L Glucose level 2 hour follow oral glucose tolerance test &lt; 7.8 mmol/L HbA1c : 4 6.5 % Normal supine blood pressure normal ECG recording Female childbearing potential Evidence clinicallysignificant renal , cardiac , bronchopulmonary , vascular , gastrointestinal , allergic , neurologic , metabolic ( diabetes , thyroid disorder , adrenal disease ) , immunodeficiency disorder , cancer , hepatitis cirrhosis . Intake grapefruit anything may affect liver enzyme function within 1 month prior dose day Clinicallyrelevant deviation normal physical examination Subjects medical disorder , condition history would impair subject 's ability participate complete study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>